Structural Development of Self Nano Emulsifying Drug Delivery Systems (SNEDDS) During in Vitro Lipid Digestion Monitored by Small-angle X-ray Scattering

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2007 Apr 27

PMID 17458683

Citations 22

Authors

Dimitrios G Fatouros

G Roshan Deen

Lise Arleth

Bjorn Bergenstahl

Flemming Seier Nielsen

Jan Skov Pedersen

Anette Mullertz

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate the structural development of the colloid phases generated during lipolysis of a lipid-based formulation in an in vitro lipolysis model, which simulates digestion in the small intestine.

Materials And Methods: Small-Angle X-Ray scattering (SAXS) coupled with the in vitro lipolysis model which accurately reproduces the solubilizing environment in the gastrointestinal tract and simulates gastrointestinal lipid digestion through the use of bile and pancreatic extracts. The combined method was used to follow the intermediate digestion products of a self nano emulsified drug delivery system (SNEDDS) under fasted conditions. SNEDDS is developed to facilitate the uptake of poorly soluble drugs.

Results: The data revealed that a lamellar phase forms immediately after initiation of lipolysis, whereas a hexagonal phase is formed after 60 min. The change of the relative amounts of these phases clearly demonstrates that lipolysis is a dynamic process. The formation of these phases is driven by the lipase which continuously hydrolyzes triglycerides from the oil-cores of the nanoemulsion droplets into mono- and diglycerides and fatty acids. We propose that this change of the over-all composition of the intestinal fluid with increased fraction of hydrolyzed nanoemulsion induces a change in the composition and effective critical packing parameter of the amphiphilic molecules, which determines the phase behavior of the system. Control experiments (only the digestion medium) or the surfactant (Cremophor RH 40) revealed the formation of a lamellar phase demonstrating that the hexagonal phase is due to the hydrolysis of the SNEDDS formulation.

Conclusions: The current results demonstrate that SAXS measurements combined with the in vitro dynamic lipolysis model may be used to elucidate the processes encountered during the digestion of lipid-based formulations of poorly soluble drugs for oral drug delivery. Thus the combined methods may act as an efficient screening tool.

Citing Articles

Development and Characterization of Olaparib-Loaded Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) for Pharmaceutical Applications.

Shin Y, Kim M, Kim C, Jeon H, Koo J, Oh J AAPS PharmSciTech. 2024; 25(7):221.

PMID: 39317842 DOI: 10.1208/s12249-024-02927-2.

In Situ Monitoring of Drug Precipitation from Digesting Lipid Formulations Using Low-Frequency Raman Scattering Spectroscopy.

Salim M, Fraser-Miller S, Berzins K, Sutton J, Gordon K, Boyd B Pharmaceutics. 2023; 15(7).

PMID: 37514154 PMC: 10383805. DOI: 10.3390/pharmaceutics15071968.

Development of a quaternary ammonium poly (amidoamine) dendrimer-based drug carrier for the solubility enhancement and sustained release of furosemide.

Murugan E, Yogaraj V Front Chem. 2023; 11:1123775.

PMID: 36874076 PMC: 9982094. DOI: 10.3389/fchem.2023.1123775.

Continuous Manufacturing and Molecular Modeling of Pharmaceutical Amorphous Solid Dispersions.

Nambiar A, Singh M, Mali A, Serrano D, Kumar R, Healy A AAPS PharmSciTech. 2022; 23(7):249.

PMID: 36056225 DOI: 10.1208/s12249-022-02408-4.

Supersaturation and Solubilization upon In Vitro Digestion of Fenofibrate Type I Lipid Formulations: Effect of Droplet Size, Surfactant Concentration and Lipid Type.

Katev V, Tsibranska-Gyoreva S, Vinarov Z, Tcholakova S Pharmaceutics. 2021; 13(8).

PMID: 34452248 PMC: 8399075. DOI: 10.3390/pharmaceutics13081287.

References

Dressman J, Berardi R, Dermentzoglou L, Russell T, Schmaltz S, Barnett J . Upper gastrointestinal (GI) pH in young, healthy men and women. Pharm Res. 1990; 7(7):756-61. DOI: 10.1023/a:1015827908309. View

Cistola D, Atkinson D, Hamilton J, Small D . Phase behavior and bilayer properties of fatty acids: hydrated 1:1 acid-soaps. Biochemistry. 1986; 25(10):2804-12. DOI: 10.1021/bi00358a011. View

Pabst G, Rappolt M, Amenitsch H, Laggner P . Structural information from multilamellar liposomes at full hydration: full q-range fitting with high quality x-ray data. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 2000; 62(3 Pt B):4000-9. DOI: 10.1103/physreve.62.4000. View

Westerman P . Physicochemical characterization of a model digestive mixture by 2H NMR. J Lipid Res. 1995; 36(12):2478-92. View

Porter C, Kaukonen A, Taillardat-Bertschinger A, Boyd B, OConnor J, Edwards G . Use of in vitro lipid digestion data to explain the in vivo performance of triglyceride-based oral lipid formulations of poorly water-soluble drugs: studies with halofantrine. J Pharm Sci. 2004; 93(5):1110-21. DOI: 10.1002/jps.20039. View

Lindstrom M, Ljusberg-Wahren H, Larsson K, Borgstrom B . Aqueous lipid phases of relevance to intestinal fat digestion and absorption. Lipids. 1981; 16(10):749-54. DOI: 10.1007/BF02535343. View

Hofmann A, Borgstrom B . Physico-chemical state of lipids in intestinal content during their digestion and absorption. Fed Proc. 1962; 21:43-50. View

LUTTON E . Phase behavior of aqueous systems of monoglycerides. J Am Oil Chem Soc. 1965; 42(12):1068-70. DOI: 10.1007/BF02636909. View

Patton J, Carey M . Inhibition of human pancreatic lipase-colipase activity by mixed bile salt-phospholipid micelles. Am J Physiol. 1981; 241(4):G328-36. DOI: 10.1152/ajpgi.1981.241.4.G328. View

10.

Rigler M, Honkanen R, Patton J . Visualization by freeze fracture, in vitro and in vivo, of the products of fat digestion. J Lipid Res. 1986; 27(8):836-57. View

11.

Christensen J, Schultz K, Mollgaard B, Kristensen H, Mullertz A . Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols. Eur J Pharm Sci. 2004; 23(3):287-96. DOI: 10.1016/j.ejps.2004.08.003. View

12.

Reymond J, Sucker H . In vitro model for ciclosporin intestinal absorption in lipid vehicles. Pharm Res. 1988; 5(10):673-6. DOI: 10.1023/a:1015987223407. View

13.

Patton J, Carey M . Watching fat digestion. Science. 1979; 204(4389):145-8. DOI: 10.1126/science.432636. View

14.

Gargouri Y, Moreau H, Verger R . Gastric lipases: biochemical and physiological studies. Biochim Biophys Acta. 1989; 1006(3):255-71. DOI: 10.1016/0005-2760(89)90012-x. View

15.

Staggers J, Hernell O, Stafford R, Carey M . Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption. 1. Phase behavior and aggregation states of model lipid systems patterned after aqueous duodenal contents of healthy adult human beings. Biochemistry. 1990; 29(8):2028-40. DOI: 10.1021/bi00460a011. View

16.

Zangenberg N, Mullertz A, Kristensen H, Hovgaard L . A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium. Eur J Pharm Sci. 2001; 14(2):115-22. DOI: 10.1016/s0928-0987(01)00169-5. View

17.

Small D . A classification of biologic lipids based upon their interaction in aqeous systems. J Am Oil Chem Soc. 1968; 45(3):108-19. DOI: 10.1007/BF02915334. View

18.

Nielsen F, Gibault E, Ljusberg-Wahren H, Arleth L, Pedersen J, Mullertz A . Characterization of prototype self-nanoemulsifying formulations of lipophilic compounds. J Pharm Sci. 2007; 96(4):876-92. DOI: 10.1002/jps.20673. View

19.

Pouton C . Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur J Pharm Sci. 2000; 11 Suppl 2:S93-8. DOI: 10.1016/s0928-0987(00)00167-6. View

20.

Pedersen B, Brondsted H, Lennernas H, Christensen F, Mullertz A, Kristensen H . Dissolution of hydrocortisone in human and simulated intestinal fluids. Pharm Res. 2000; 17(2):183-9. DOI: 10.1023/a:1007517414200. View